Rapid detection and surveillance of cfiA-positive Bacteroides fragilis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development (JP21fk0108133)
This publication has 40 references indexed in Scilit:
- Prevalence of Antimicrobial Resistance among Clinical Isolates of Bacteroides fragilis Group in Canada in 2010-2011: CANWARD Surveillance StudyAntimicrobial Agents and Chemotherapy, 2012
- Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experienceClinical Microbiology and Infection, 2011
- Evaluation of a new meropenem–EDTA double-ended Etest strip for the detection of the CfiA metallo-β-lactamase in clinical isolates of Bacteroides fragilisClinical Microbiology and Infection, 2008
- Bacteroides: the Good, the Bad, and the Nitty-GrittyClinical Microbiology Reviews, 2007
- National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends in the United States from 1997 to 2004Antimicrobial Agents and Chemotherapy, 2007
- Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility surveyInternational Journal of Antimicrobial Agents, 2006
- Molecular characterization of imipenem-resistant, cfiA-positive Bacteroides fragilis isolates from the USA, Hungary and KuwaitJournal of Medical Microbiology, 2004
- Bacteremia Due to Bacteroides fragilis Group: Distribution of Species, β-Lactamase Production, and Antimicrobial Susceptibility PatternsAntimicrobial Agents and Chemotherapy, 2003
- Expression of the carbapenemase gene (cfiA) in Bacteroides fragilisJournal of Antimicrobial Chemotherapy, 2000
- Antimicrobial Resistance and Clinical Outcome of Bacteroides Bacteremia: Findings of a Multicenter Prospective Observational TrialClinical Infectious Diseases, 2000